{
    "Title": "Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate",
    "URL": "https://doi.org/10.1371/journal.pntd.0004007",
    "Published": "September 4, 2015",
    "Subject_Areas": [
        "Chikungunya virus",
        "Viral vaccines",
        "Mouse models",
        "Chikungunya infection",
        "Vaccine development",
        "Vaccines",
        "Viral load",
        "Attenuated vaccines"
    ],
    "Authors": {
        "Kenneth S Plante": [
            "Institute for Human Infections and Immunity, Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Shannan L. Rossi": [
            "Institute for Human Infections and Immunity, Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Nicholas A. Bergren": [
            "Institute for Human Infections and Immunity, Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Robert L. Seymour": [
            "Institute for Human Infections and Immunity, Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Scott C. Weaver": [
            "Institute for Human Infections and Immunity, Sealy Center for Vaccine Development and Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ]
    }
}